Protecting Women's Health: Visionary's Precision Cervical Cancer Screening Public Welfare Activity Brings Health Blessings to Women

TORONTO,March 11,2025-- On March 8,2025,the public welfare activity of "Celebrating International Women\'s Day and Caring for Women\'s Health" and the "Global Press Conference of E7 Pro

03-11

MINISO Group Will Report December Quarter and Full Year 2024 Financial Results on March 21, 2025

GUANGZHOU,China,March 7,2025-- MINISO Group Holding Limited (NYSE: MNSO; HKEX: 9896) ("MINISO","MINISO Group" or the "Company"),a global value retailer offering a variety

03-10

Manulife Extends Strategic Partnership with CUHK Medical Centre to Include Histotripsy in its Holistic "Medical Professional Support Service"

Histotripsy is an FDA-approved technology that offers liver cancer patients a non-invasive,painless,and highly effective treatment option

03-10

What is the new momentum endorsing China's goal?

BEIJING,March 7,2025-- A news report by China.org.cn on China\'s GDP growth target for 2025:  

03-10

From the Court to Living Room: Govee's Smart Lighting Enhances Every Gametime Moment

DALLAS,March 7,2025-- As the Official Smart Lighting Sponsor of the Dallas Mavericks,Govee aims to revolutionize the game day experience for Sports fans with dynamic,interactive lighting solutions tha

03-10

MWC 2025 | Huawei Showcases Scenario-based Solutions at MWC For Intelligent Healthcare

BARCELONA,Spain,March 7,2025-- During the Mobile World Congress (MWC) 2025,Huawei held a global healthcare industry session themed Digital Intelligence Drives Inclusive Healthcare. Expertsshared their

03-10

SURVIVE TOGETHER IN A NEW CHALLENGING TEAM EXPERIENCE FROM ZERO LATENCY VR, IN WARHAMMER 40,0000 SPACE MARINE VR - THREAT: LETHAL

Prepare for the most challenging free-roam VR experience available. Dive into the intensity of Threat: Lethal with your squad at Zero Latency VR locations globally.

03-10

Manulife Extends Strategic Partnership with CUHK Medical Centre to Include Histotripsy in its Holistic "Medical Professional Support Service"

Histotripsy is an FDA-approved technology that offers liver cancer patients a non-invasive,painless,and highly effective treatment option

03-10

Forest City Golf Resort: More Than Just Golf

03-10

SanyouBio Launches 73 Whole-Series Bispecific Reference Antibody Products, Facilitating New Breakthroughs in Bispecific Drug Development

SHANGHAI,March 5,2025-- SanyouBio announced today the official launch of 73 whole-series bispecific antibody reference products,covering globally approved and representative clinical-stage bispecific

03-06